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Comparing the efficacy of a hypnosis-based
group intervention to improve emotionnal
distress, fatigue, sleep difficulties and quality
of life in breast and prostate cancer patients
Hypnosis: 6 x 120 min. Self-care techniques + hypnosis exercises.

















































• Demographics and medical history
• Emotional distress (Hospital Anxiety and 
Depression Scale)
• Fatigue & Global Health Status
(European Organization for Research and 
Treatment of Cancer – Core Questionnaire)
• Sleep difficulties (Insomnia Severity 
Index)
Results
Breast cancer: positive effects on :
 Anxiety (p = ,000)
 Depression (p = ,001)
 Fatigue (p = ,003)
 Sleep difficulties (p = ,018)
 Global health status (p = ,020)
Prostate cancer: No effect
Control groups : No effect
Why?
Results
Baseline differences between BC and PC patients:
 Psychological state & Sociodemographic data
 BC > PC: Anxiety (p = ,048) ; Fatigue (p = ,003) ; Sleep difficulties (p = ,013)
 PC > BC: Age (p = ,000)
 Treatments received:
 BC: ongoing treatment; multimodal treatments
 PC: off treatment; single treatment
Possible explanation of our results
Discussion
Efficacy of the intervention: contrasted results 
Explanatory hypotheses: 
Baseline differences in patients’ psychological state
Format of the intervention
Interest for the intervention
Alosaimi et al., 2014 ; Bhattacharjeen & Banerjee, 2016; 
Linden et al., 2012 ; McLean et al., 2011 ; Mo et al., 2009; 
Nekolaichuk et al., 2011 ; Nolen-Hoeksema, 2001 ; Tang et 





Small samples, with no a-priori sample size calculation
Non-randomized design
Baseline differences between BC and PC patients
Format of the intervention
Clover et al., 2015 ; Mo et al., 2009; Nekolaichuk et 
al., 2011 ; Visser, 2013
Conclusion
General conclusions
Originality of the study 
Comparison between BC and PC patients
 Importance of the gender 
Research perspectives
 Participants: no baseline differences, emotional distress, treatment 
journey
 Intervention: same moment, same length 
 Evaluation: randomized-controlled design 
Thank you for your
attention!
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